Bold type indicates statistical significance.

BM, bone marrow; DFS, disease-free survival; NRM, nonrelapse mortality; OS, overall survival; PBSC, peripheral blood stem cells.

Data are from Lee et al.¹⁵  Baseline is the 8/8 transplants (n = 1840) against the 7/8 transplants. Ninety-two percent of hematopoietic cell transplantations were performed with BM. Models were adjusted for disease, disease stage, Karnofsky performance status, donor–patient cytomegalovirus serology, patient race and age, use of T-cell depletion, use of total body irradiation, graft source, donor age, patient–donor sex match, and year of transplantation.

Data are from Fürst et al.¹⁶  Baseline is the 8/8 transplants (n = 1511) against the 7/8 transplants. Eighty-seven percent of hematopoietic cell transplantations were performed with PBSC. Models were adjusted for disease stage, donor–patient cytomegalovirus serology, patient age, use of T-cell depletion, conditioning regimen intensity, patient–donor sex match, year of transplantation, time to transplantation, and donor origin (national vs international).

Shown are the relative risk values followed by the 95% confidence intervals in parentheses.